表紙
市場調査レポート

無針ドラッグデリバリー技術の世界市場

Global Needle-free Drug Delivery Technologies market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 322210
出版日 ページ情報 英文 116 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
無針ドラッグデリバリー技術の世界市場 Global Needle-free Drug Delivery Technologies market 2015-2019
出版日: 2014年12月24日 ページ情報: 英文 116 Pages
概要

無針ドラッグデリバリー技術とは、従来の針を使わずに患者の体内に薬剤やワクチンを送達する技術です。最大の目的は、NSI(軟部組織感染症)と合併症を減らし、患者コンプライアンスと患者の安心を高めることです。世界の無針ドラッグデリバリー技術市場は、2014年から2019年の期間中にCAGRが13.50%成長する見込みとなっております。

当レポートでは、世界の無針ドラッグデリバリー技術市場について調査分析を行い、市場概要、セグメンテーション別考察、地域別考察、主要企業などについてまとめています。

第1章 エグゼクティブサマリー

第2章 略語一覧

第3章 レポートの範囲

  • 市場概要
  • 商品一覧

第4章 市場調査の方法

  • 市場調査のプロセス
  • 調査方法

第5章 イントロダクション

第6章 NSI(軟部組織感染症):世界的な負担

第7章 無針ドラッグデリバリー技術

  • 持続可能なソリューション
  • 利点
  • ISO 21649-2006
  • 最新の発展

第8章 市場の状況

  • 市場概要
  • 市場の規模と予測
  • ファイブフォース分析

第9章 市場セグメンテーション:製品別

第10章 世界のジェット式注射器市場

  • 市場概要
  • 市場の規模と予測

第11章 世界の経皮貼布市場

  • 市場概要
  • 世界のマイクロ針市場
  • 世界のナノパッチ市場

第12章 市場セグメンテーション:用途別

  • 世界のインスリンデリバリー市場
  • 世界のワクチン市場
  • 世界の小児科用注射市場

第13章 地域別セグメンテーション

第14章 購入基準

第15章 市場成長促進因子

第16章 促進因子とその影響

第17章 市場の課題

第18章 促進因子と課題の影響

第19章 市場動向

第20章 動向とその影響

第21章 ベンダーの状況

  • 競合シナリオ
  • 市場シェア分析
  • その他の主要ベンダー

第22章 主要ベンダー分析

  • 3M
  • Antares Pharma
  • Bioject Medical Technologies
  • Glide Pharmaceutical Technologies
  • PharmaJet
  • Zogenix

第23章 本シリーズのその他のレポート

目次
Product Code: IRTNTR4938

About Needle-free Drug Delivery Technology

Needle-free drug delivery technologies are used to deliver drugs or vaccines into a patient's body without the need for a traditional needle. The primary objectives of the development of these technologies are to eliminate NSI and its associated complications and increase patient compliance and comfort. Needle-free drug delivery systems include jet injectors, microneedles, nanopatches, and vaccine implants. The advantages of these systems over conventional syringes are expanded immunization coverage, decreased healthcare costs, and increased patient compliance. Needle-free systems expand the range of molecules that can be delivered transdermally with improved efficiency and enhance the efficacy of the drug or vaccine. Microneedles increase the efficacy of vaccines by targeting them to antigen-presenting cells mainly found just beneath the stratum corneum of the skin.

TechNavio's analysts forecast the Global Needle-free Drug Delivery Technologies market to grow at a CAGR of 13.50 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Needle-free Drug Delivery Technologies market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various needle-free drug delivery systems with active mechanisms for skin permeation such as velocity, ultrasound, iontophoresis, thermo ablation, and electrophoresis. This mode of drug delivery includes:

  • Jet Injectors
  • Transdermal Patches (Microneedles, Nanopatches)

TechNavio's report, the Global Needle-free Drug Delivery Technologies Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Needle-free Drug Delivery Technologies market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • 3M
  • Antares Pharma
  • Bioject Medical Technologies
  • Glide Pharmaceutical Technologies
  • PharmaJet
  • Zogenix

Other Prominent Vendors

  • Akra Dermojet
  • Alkermes
  • Alza
  • Anthony Products
  • Aradigm
  • Bespak
  • BioValve Technologies
  • Crossject
  • D'Antonio Consultants International
  • European Pharma Group
  • Evonik Industries
  • Iomai
  • Injex Pharma
  • Lohmann Therapie-Systeme
  • Medical International Technologies
  • Merck
  • National Medical Products
  • Nemaura
  • Neolabs Solutions
  • Pacira Pharmaceuticals
  • Penjet
  • Spirit Healthcare
  • Valeritas
  • Zosano
  • Zynerba Pharmaceuticals

Market Driver

  • Increased Safety Concerns
  • For a full, detailed list, view our report

Market Challenge

  • Technical Issues
  • For a full, detailed list, view our report

Market Trend

  • Mandatory Use of Safety Injection Practices
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. NSIs - A Global Burden

    • 06.1.1. A Temporary Solution

07. Needle-free Drug Delivery Technologies

  • 07.1. A Sustainable Solution
  • 07.2. Advantages
  • 07.3. ISO 21649-2006
  • 07.4. Latest Developments

08. Market Landscape

  • 08.1. Market Overview
  • 08.2. Market Size and Forecast
  • 08.3. Five Forces Analysis

09. Market Segmentation by Product Type

10. Global Jet Injectors Market

  • 10.1. Market Overview
    • 10.1.1. Product Portfolio
  • 10.2. Market Size and Forecast

11. Global Transdermal Patches Market

  • 11.1. Market Overview
    • 11.1.1. Product Portfolio
    • 11.1.2. Market Size and Forecast
  • 11.2. Global Microneedles Market
    • 11.2.1. Market Overview
    • 11.2.2. Market Size and Forecast
  • 11.3. Global Nanopatches Market
    • 11.3.1. Market Overview
    • 11.3.2. Market Size and Forecast

12. Market Segmentation by Application

  • 12.1. Global Insulin Delivery Market
    • 12.1.1. Market Size and Forecast
  • 12.2. Global Vaccines Market
    • 12.2.1. Market Size and Forecast
  • 12.3. Global Pediatric Injections Market
    • 12.3.1. Market Size and Forecast

13. Geographical Segmentation

14. Buying Criteria

15. Market Growth Drivers

16. Drivers and their Impact

17. Market Challenges

18. Impact of Drivers and Challenges

19. Market Trends

20. Trends and their Impact

21. Vendor Landscape

  • 21.1. Competitive Scenario
    • 21.1.1. Key News
    • 21.1.2. Mergers and Acquisitions
  • 21.2. Market Share Analysis 2014
  • 21.3. Other Prominent Vendors

22. Key Vendor Analysis

  • 22.1. 3M
    • 22.1.1. Key Facts
    • 22.1.2. Business Description
    • 22.1.3. Business Segmentation
    • 22.1.4. Revenue by Business Segmentation
    • 22.1.5. Revenue Comparison 2013 and 2014
    • 22.1.6. Sales by Geography
    • 22.1.7. Business Strategy
    • 22.1.8. Key Developments
    • 22.1.9. SWOT Analysis
  • 22.2. Antares Pharma
    • 22.2.1. Key Facts
    • 22.2.2. Business Description
    • 22.2.3. Business Segmentation
    • 22.2.4. Revenue by Business Segmentation
    • 22.2.5. Revenue Comparison 2013 and 2014
    • 22.2.6. Sales by Geography
    • 22.2.7. Business Strategy
    • 22.2.8. Key Developments
    • 22.2.9. SWOT Analysis
  • 22.3. Bioject Medical Technologies
    • 22.3.1. Key Facts
    • 22.3.2. Business Description
    • 22.3.3. Business Segmentation
    • 22.3.4. Revenue by Business Segmentation
    • 22.3.5. Revenue Comparison 2013 and 2014
    • 22.3.6. Sales by Geography
    • 22.3.7. Business Strategy
    • 22.3.8. Key Developments
    • 22.3.9. SWOT Analysis
  • 22.4. Glide Pharmaceutical Technologies
    • 22.4.1. Key Facts
    • 22.4.2. Business Description
    • 22.4.3. Business Segmentation
    • 22.4.4. Revenue by Business Segmentation
    • 22.4.5. Revenue Comparison 2013 and 2014
    • 22.4.6. Sales by Geography
    • 22.4.7. Business Strategy
    • 22.4.8. Key Developments
    • 22.4.9. SWOT Analysis
  • 22.5. PharmaJet
    • 22.5.1. Key Facts
    • 22.5.2. Business Description
    • 22.5.3. Business Segmentation
    • 22.5.4. Revenue by Business Segmentation
    • 22.5.5. Revenue Comparison 2013 and 2014
    • 22.5.6. Sales by Geography
    • 22.5.7. Business Strategy
    • 22.5.8. Key Developments
    • 22.5.9. SWOT Analysis
  • 22.6. Zogenix
    • 22.6.1. Key Facts
    • 22.6.2. Business Description
    • 22.6.3. Business Segmentation
    • 22.6.4. Revenue by Business Segmentation
    • 22.6.5. Revenue Comparison 2013 and 2014
    • 22.6.6. Sales by Geography
    • 22.6.7. Business Strategy
    • 22.6.8. Key Developments
    • 22.6.9. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Executive Summary of Global Needle-free Drug Delivery Technologies Market 2014-2019
  • Exhibit 3: NSIs - Facts and Figures
  • Exhibit 4: Percentage of NSIs at Different Stages of the Injection Process
  • Exhibit 5: Percentage of Professionals Exposed to NSIs
  • Exhibit 6: Various Needle-free Drug Delivery Systems
  • Exhibit 7: Benefits of Needle-free Drug Delivery Devices
  • Exhibit 8: Disadvantages of Needle-free Drug Delivery Devices
  • Exhibit 9: Latest Developments by WHO
  • Exhibit 10: Global Needle-free Drug Delivery Technologies Market 2014-2019 (US$ million)
  • Exhibit 11: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type
  • Exhibit 12: Revenue (US$ million) and CAGR Comparison of Global Needle-free Drug Delivery Technologies Market Segments 2014 and 2019
  • Exhibit 13: Snapshot of Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019
  • Exhibit 14: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019 (US$ million)
  • Exhibit 15: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014
  • Exhibit 16: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014 and 2019 (in percent)
  • Exhibit 17: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019
  • Exhibit 18: YoY Growth Rate of Global Needle-free Drug Delivery Technologies Market Segments 2014-2019
  • Exhibit 19: Components of Needle-free Jet Injector
  • Exhibit 20: Ideal Characteristics of a Jet Injector
  • Exhibit 21: Advantages of Jet Injectors
  • Exhibit 22: Global Jet Injectors Market 2014-2019 (US$ million)
  • Exhibit 23: Global Transdermal Patches Market Segmentation by Product Type
  • Exhibit 24: Global Transdermal Patches Market Segmentation by Product Type 2014-2019 (US$ million)
  • Exhibit 25: Global Transdermal Patches Market Segmentation by Product Type 2014 and 2019
  • Exhibit 26: Global Transdermal Patches Market Segmentation by Product Type 2014-2019
  • Exhibit 27: Yoy Growth Rate of Global Transdermal Patches Market Segments 2014-2019
  • Exhibit 28: Global Transdermal Patches Market 2014-2019 (US$ million)
  • Exhibit 29: Comparison of Syringe and Microneedle Drug Administration
  • Exhibit 30: Types of Microneedles
  • Exhibit 31: Silicon Microneedles
  • Exhibit 32: Metal Microneedles
  • Exhibit 33: Advantages of Microneedles
  • Exhibit 34: Disadvantages of Microneedles
  • Exhibit 35: Global Microneedles Market 2014-2019 (US$ million)
  • Exhibit 36: Global Nanopatches Market 2014-2019 (US$ million)
  • Exhibit 37: Global Needle-free Drug Delivery Technologies Market Segmentation by Application
  • Exhibit 38: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014
  • Exhibit 39: Revenue (US$ million) and CAGR Comparison of Global Needle-free Drug Delivery Technologies Market Segments by Application 2014 and 2019
  • Exhibit 40: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2019
  • Exhibit 41: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014-2019 (US$ million)
  • Exhibit 42: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014-2019
  • Exhibit 43: Global Insulin Delivery Market 2014-2019 (US$ million)
  • Exhibit 44: Global Vaccines Market 2014-2019 (US$ million)
  • Exhibit 45: Global Pediatric Injections Market 2014-2019 (US$ million)
  • Exhibit 46: Global Needle-free Drug Delivery Technologies Market Segmentation by Geography 2014
  • Exhibit 47: Buying Criteria of Global Needle-free Drug Delivery Technologies Market 2014
  • Exhibit 48: Drivers of Global Needle-free Drug Delivery Technologies Market
  • Exhibit 49: Challenges of Global Needle-free Drug Delivery Technologies Market
  • Exhibit 50: Bioject: Needle-free Drug Delivery Pipeline Portfolio
  • Exhibit 51: 3M: Business Segmentation 2014
  • Exhibit 52: 3M: Business Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 53: 3M: Sales by Geography (in US$ million)
  • Exhibit 54: Celgene: Business Segmentation by Revenue 2013 and 2014
  • Exhibit 55: Celgene: Sales by Geography 2014 (Pharmaceuticals Division)
  • Exhibit 56: Celgene: Sales by Geography 2014 (Diagnostics Division)
  • Exhibit 57: Bioject: Business Segmentation by Revenue 2014
  • Exhibit 58: Bioject: Business Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 59: Bioject: Sales by Geography 2014
  • Exhibit 60: Glide Pharmaceutical Technologies: Business Segmentation
  • Exhibit 61: Glide Pharmaceutical Technologies: Revenue by Business Segmentation 2014
  • Exhibit 62: Glide Pharmaceutical Technologies: Revenue by Business Segmentation 2013 and 2014 (US$ million)
  • Exhibit 63: Glide Pharmaceutical Technologies: Revenue by Geographical Segmentation 2014
  • Exhibit 64: PharmaJet: Business Segmentation by Revenue 2014
  • Exhibit 65: PharmaJet: Business Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 66: PharmaJet: Sales by Geography 2014
  • Exhibit 67: Zogenix: Business Segmentation by Revenue 2014
  • Exhibit 68: Zogenix: Business Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 69: Zogenix: Sales by Geography 2014
Back to Top